An unusual case of reactivated latent pulmonary cryptococcal infection in a patient after short‐term steroid and azathioprine therapy: a case report

Abstract

Background Cryptococcus is one of the major fungal pathogens infecting the lungs. Pulmonary cryptococcal infection is generally considered a community-acquired condition caused by inhalation of dust contaminated with fungal cells from the environment. Here, we report a case developing pulmonary cryptococcosis 3 months after hospital admission, which has rarely been reported before. Case presentation A 73-year-old female patient who was previously immunocompetent experienced persistent dry cough for 2 weeks, 3 months after admission. Chest computed tomography (CT) showed a new solitary pulmonary nodule developed in the upper lobe of the left lung. Staining and culture of expectorated sputum smears were negative for bacteria, acid-fast bacilli, or fungus. The patient then underwent biopsy of the lesion. Histopathology findings and a positive serum cryptococcal antigen titer (1:8) indicated pulmonary cryptococcosis. Daily intravenous 400 mg fluconazole was administered initially followed by oral fluconazole therapy. Follow-up chest CT after 3 months of antifungal therapy showed complete disappearance of the pulmonary nodule. Respiratory symptoms of the patient also resolved. A complete investigation excluded the possibility of a patient-to-patient transmission or primarily acquiring the infection from the hospital environment. Based on the patient’s history of exposure to pigeons before admission and recent steroid and azathioprine use after admission for the treatment of myasthenic crisis, reactivation of a latent pulmonary cryptococcal infection acquired before admission, in this case, is impressed. Conclusions Although rarely reported, pulmonary cryptococcal infection should be included in the differential diagnosis of hospitalized patients with respiratory symptoms, especially in those with predisposing risk factors. Chest image studies and further surgical biopsy are needed for confirmation.

Pulmonary infection in traumatic brain injury patients undergoing tracheostomy: predicators and nursing care

“…Pulmonary infection seriously affects the prognosis of patients with STBI, and infection should be prevented and controlled in a timely and effective manner [ 38 ]. The clinical treatment and nursing operations should strictly abide by the aseptic operating procedures, including tracheostomy, dressing change, and tracheal tube care throughout the entire process.…”

Hospital Acquired Sepsis, Disease Prevalence, and Recent Advances in Sepsis Mitigation

“…Similarly, invasive or disseminated Cryptococcal infections are associated with immunocompromised patients, particularly HIV patients, cancer patients and pulmonary cryptococcosis [ 28 ]. The main species involved in IFIs are C. neoformans and C. gattii ; however, the cases are primarily community acquired via inhalation of fungal spores present in the environment [ 81 ].…”

Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients

“…The advantages in diagnostic strategies have come with the implementation of molecular detection techniques such as multiplex reverse transcription PCR considering detection of cryptococcal antigen from respiratory specimens might assist the diagnosis of pulmonary cryptococcosis, but it is important to note there is very few evidence towards its efficacy as a diagnostic tool. Anecdotical cases have been reported from reactivated latent pulmonary crypto- coccal infection in hospitalized patients [32] and invasive C. neoformans blood stream infection in the context of severe COVID-19 pneumonia [33].…”